- 英文名称
- (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanaminium (2R)-hydroxy(phenyl)ethanoate
- 分子式
- C17H17F2NO3
- 分子量
- 321.32
- 中文别名
- (1R,2S)-2-(3,4-DIFLUOROPHENYL)CYCLOPROPANAMINIUM (2R)-HYDROXY(PHENYL)ETHANOATE别名 (ALPHAR)-ALPHA-HYDROXYBENZENEACETIC ACID COMPD. WITH (1R,2S)-2-(3,4-DIFLUOROPHENYL)CYCLOPROPA;(1R,2S)-2-(3,4-二氟苯基)环丙胺/(R)-扁桃酸盐 1G;(1S,2R)-2-(3,4-二氟苯基)环丙胺扁桃酸盐(替卡格雷中间体) 50MG;52(1R,2S)-2-(3,4-二氟苯基)环丙胺;替卡格雷中间体4;(1R,2S)-2-(3,4-二氟苯基)环丙胺 (R)-扁桃酸盐;反式(1R,2S)-2- (2,3-二氟苯基)环丙胺扁桃酸盐;(1R,2S)-2-(3,4-二氟苯基)环丙胺 (R)-扁桃酸盐(1:1); (1R,2R)-2-(3,4-difluorophenyl)cyclopropanamine(S)-(carboxylato(phenyl)methyl)holmium;(1R,2S)-2-(3,4-Difluorophenyl)cyclopropanaMine (2R)-Hydroxy(phenyl)ethanoate;(αR)-α-Hydroxybenzeneacetic Acid coMpd. with (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanaMine;trans-(1R,2S)-2-(2,3-difluorophenyl)cyclopropylaMine Mandelat;(1R,2S)-2-(3,4-Difluorophenyl)cyclopropanaminium (2R)-hydroxy(phenyl)ethanoate;(alphaR)-alpha-Hydroxybenzeneacetic acid compd. with (1R,2S)-2-(3,4-difluorophenyl)cyclopropanamine;(αR)-(1R,2S)-α-hydroxy-Benzeneacetic acid-coMpd.with 2-(3,4-difluorophenyl)cyclopropanaMine(1:1);Ticagrelor InterMediate 4
- 用途
- 化学合成，医药替卡格雷中间体；是制备口服活性可逆P2Y12受体拮抗剂（如Ticagrelor）的中间体，用于预防血栓形成。
